Q. Dwight Lewis is responsible for managing all quality-related functions to ensure that Mayne Pharma’s U.S. pharmaceutical operations – which range from laboratories to manufacturing lines – continue to comply with global regulatory agency and industry standards.
Shire has announced that James Bowling, Interim Chief Financial Officer, has notified the Board...
Antibiotic maker Cubist Pharmaceuticals said that Michael Bonney will retire as CEO at the end...
Eli Lilly and Company has announced plans to conclude production and pursue a sale of one of its...
Vetter, a contract development and manufacturing organization (CDMO), today officially announced a series of adjustments to its Development Service related structures designed to support its customer base.
West Pharmaceutical Services said today that Donald E. Morel, Jr., Ph.D., Chairman of the Board and Chief Executive Officer, has announced his intention to retire at the company's Annual Meeting in May 2015.
A former senior finance analyst at Merck & Co. is facing an insider trading charge after authorities said Tuesday that he passed secrets to a friend he met at college that earned $722,000 in illegal profits.
Lyophilization Services of New England (LSNE), a New Hampshire based contract manufacturing organization, is pleased to announce that Thomas McGrath has been named Vice President of Quality.
Novartis confirmed today that following completion of the transactions with GlaxoSmithKline and Eli Lilly and Company in the coming months, that the three business leaders of the Novartis divisions at the center of the transaction will leave the Executive Committee of Novartis.
Takeda Pharmaceuticals International has announced that John Boslego, MD, has been named Senior Vice President and Head of Development for Takeda’s Global Vaccine Business Unit, effective December 1, 2014.
West Pharmaceutical Services, Inc. has appointed Karen Flynn President of the company's Pharmaceutical Packaging Systems business. Flynn brings more than 28 years of experience to this role. Most recently, she held the position of President, Americas Region, Pharmaceutical Packaging Systems, where she was responsible for the Americas regional business segment, including both the manufacturing and commercial aspects of the business.
GEA Pharma Systems (GPS) has announced a group restructure and appointments as it embraces a new corporate philosophy to overcome competitive challenges, expand and develop new markets and customers.
Ireland's Minister for Jobs, Enterprise & Innovation, Richard Bruton TD, today announced that Optel Vision, a Canadian company specializing in Track & Trace and vision inspection solutions for the manufacturing industries, is to create 140 new jobs in Limerick as part of a new European expansion.
Biogen Idec today announced that Olivier Danos, Ph.D., has joined the company as senior vice president, Gene Therapy. Dr. Danos reports directly to Douglas Williams, Ph.D., executive vice president, Research and Development, and is a member of Biogen Idec’s Senior Research and Development Leadership Team.
Merck KGaA today announced that the Board of Partners has promoted Stefan Oschmann to the position of Deputy CEO and Vice Chairman of the Executive Board. Concurrently, Belén Garijo was appointed to the Executive Board to take over leadership for the Pharma business.
Auxilium Pharmaceuticals said Tuesday it is cutting 30 percent of its workforce, about 190 jobs, as part of a restructuring of its operations that will save it at least $75 million a year.
EMD Serono announced today that Drew Young has joined the company as Senior Vice President, Neurology and Immunology. In this capacity, he will be responsible for leading the strategic direction of the U.S. Neurology and Immunology franchise, including future products.
DuPont will pay a fine of $1.275M to settle a federal complaint over eight chemical releases from a Kanawha County production facility, one of which killed a worker. The Department of Justice and U.S. Environmental Protection Agency said the settlement announced in a statement Wednesday resolves several alleged violations of federal law.
Moberg Pharma AB today announced that its head of U.S. operations, Steve Cagle, has announced his resignation. In order to secure a smooth transition, he will remain in his position until end of January 2015 at the latest.
That’s Nice LLC, a research-focused strategic marketing agency dedicated to life science markets, today announced the formation of a new dedicated team that will support clients with comprehensive strategic content development.
Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Robert Hureau as executive vice president and chief financial officer. Hureau brings 25 years of experience and extensive financial expertise spanning the medical technology/life sciences, manufacturing and consumer sectors.
Biogen Idec announced that Donald R. Johns, M.D., has joined the company as vice president, leading Biogen Idec’s amyotrophic lateral sclerosis (ALS) Innovation Hub (ALS iHub).
Eli Lilly and Co. says it will close its Elanco animal enzyme plant in Terre Haute by early 2016 as part of a consolidation push. Lilly spokesman Ed Sagebiel tells the Tribune-Star the Indianapolis-based company is consolidating all of its animal enzyme manufacturing to a site in Great Britain.
GE Healthcare Life Sciences today announced the appointment of Olivier Loeillot as General Manager, Asia Commercial for BioProcess. In this newly-created role Olivier will oversee commercial activities in the fast-moving Asian market for GE Healthcare Life Science’s rapidly growing BioProcess business.
Bioprocess Technology Consultants, Inc. (BPTC), a technical, and regulatory consulting company for the global biopharmaceutical industry, has promoted Susan Dana Jones, Ph.D., and Thomas C. Ransohoff to Principal Consultants.
Astellas has appointed Moyra Knight as the head of corporate and employee communications in the Americas region. Knight will report directly to Jeff Winton, senior vice president, chief communications officer.
Dendreon Corporation announced that its board of directors has appointed W. Thomas Amick as president and chief executive officer, effective immediately. Mr. Amick has also been appointed to the company’s board of directors.
Amgen said it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that trounced Wall Street expectations.
ISPE has hired John Bournas as President and CEO, succeeding Nancy Berg who announced plans to leave the Society last fall. Mr. Bournas takes the helm at ISPE with extensive competencies in the healthcare association industry as well as significant international experience.
- Page 1